Advertisement
Screener

CONTEXT THERAPEUTICS INC. (CNTX) Form D

CONTEXT THERAPEUTICS INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-05-16: Federal exemption Rule 506(b); Types of securities offered Equity; SecurityToBeAcquired; Date of first sale 2024-05-06; Total offering amount $99,998,250.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-05-16Rule 506(b)Equity; SecurityToBeAcquired2024-05-06$99,998,250$99,992,767$5,48326

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
NANOVIRICIDES, INC. (NNVC)United States$0.031B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
BriaCell Therapeutics Corp. (BCTX)$0.037B
PMGC Holdings Inc. (ELAB)United States$0.037B
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05